Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

28.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.1K
Gene Therapy00:59

Gene Therapy

4.8K
No description available
4.8K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.5K
No description available
3.5K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.9K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.3K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Identity and psychoanalysis: particularity and universality of the Jewish question according to Freud].

Vesalius : acta internationales historiae medicinae·2001
Same author

[The psychopathology of democracy].

Frenesie·1992
Same author

[Not Available].

Frenesie·1989
Same author

[Not Available].

Frenesie·1988
Same author

[Not Available].

Frenesie·1988
Same author

[Not Available].

Frenesie·1987

Related Experiment Video

Updated: Apr 4, 2026

Transnuclear Mice with Pre-defined T Cell Receptor Specificities Against Toxoplasma gondii Obtained Via SCNT
13:36

Transnuclear Mice with Pre-defined T Cell Receptor Specificities Against Toxoplasma gondii Obtained Via SCNT

Published on: October 1, 2010

14.7K

[Somatic gain, somatic transfer and somatic neurosis]

J Chemouni1

  • 1Psychologie clinique et pathologique (Université de Caen), Lisieux.

Annales Medico-Psychologiques
|June 1, 1996
PubMed
Summary

The concept of "gain" explains how somatic disorders develop and are managed. Somatic neurosis arises from the psychological benefits of somatization, impacting patient treatment.

Area of Science:

  • Psychiatry
  • Psychosomatic Medicine
  • Medical Psychology

Background:

  • Somatic disorders are often imbued with meaning from their onset.
  • The integration of somatic symptoms into a patient's psycho-somatic economy is crucial.

Observation:

  • The author introduces the term "gain" to describe the meaning and economic adjustment derived from somatization.
  • This "gain" is integral to the development of somatic disorders and influences therapeutic approaches.

Findings:

  • Psychic disorders stemming from somatic ailments can manifest as neurosis, influenced by the individual's mental state.
  • The term "somatic neurosis" is proposed for neurotic consequences of somatic disorders, linked to the "gain" of somatization.
  • Unconscious issues displaced onto somatic symptoms contribute to somatic neurosis.

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.1K
Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation
08:06

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation

Published on: May 5, 2023

2.6K

Related Experiment Videos

Last Updated: Apr 4, 2026

Transnuclear Mice with Pre-defined T Cell Receptor Specificities Against Toxoplasma gondii Obtained Via SCNT
13:36

Transnuclear Mice with Pre-defined T Cell Receptor Specificities Against Toxoplasma gondii Obtained Via SCNT

Published on: October 1, 2010

14.7K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.1K
Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation
08:06

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation

Published on: May 5, 2023

2.6K

Implications:

  • Understanding the "gain" in somatization is essential for effective therapeutic strategies.
  • Defining the psychic processing of physical illness as "somatic transfer" offers heuristic and therapeutic value.
  • This framework aids in comprehending the interplay between psychological factors and physical symptoms in somatic disorders.